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Received April 23, 2012; accepted August 25, 2012AbstractBackground: Reciprocal translocation is the most common type of translocation; however, there are only a few studies that address the
indications for reciprocal translocation in amniocentesis. Here we share our data, based on 30 years’ experience in a single tertiary center, to
investigate the rates and indications for amniocentesis in cases of reciprocal translocations.
Methods: A retrospective review of 16,749 pregnant women, who underwent midtrimester amniocentesis between January 1981 and December
2010, was conducted. Seventy-four cases of reciprocal translocation were identified.
Results: The percentage of reciprocal translocations in all amniocentesis cases was 0.44% (74/16,749); of these 74 cases, 56 were balanced and
18 unbalanced. De novo abnormality occurred in 23 cases, which constituted 31.1% of all reciprocal translocations. The three major indications
for amniocentesis with a diagnosis of reciprocal translocation included advanced maternal age (AMA, 52.7%), a parent with an abnormal
karyotype (17.6%), and abnormal biochemical markers in the maternal serum (12.2%). For individual types of reciprocal translocations
(balanced and unbalanced), except for the presence of abnormal biochemical markers in maternal serum, both AMA and a parent with an
abnormal karyotype were primary indications for amniocentesis. However, the highest percentage of reciprocal translocations in all amnio-
centesis cases was found in cases involving a parent with an abnormal karyotype (5.16%, 13/252).
Conclusion: Patients with a parent who carries an abnormal karyotype should be encouraged to undergo amniocentesis in prenatal consultation,
since the risk of a diagnosis of reciprocal translocation can be particularly high.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Translocations are chromosomal abnormalities that occur
when chromosomes break and the fragments rejoin other
chromosomes. When two nonhomologous chromosomes break
and exchange fragments, new chromosomes, called derivative
chromosomes, are formed. The clinical significance of trans-
location has been a higher risk of pregnancy wastage.1,2
Reciprocal translocation is the most common type of trans-
location; it can further be classified into balanced and unbal-
anced rearrangements.3 There was no loss or increase of
genetic materials in balanced translocations; however, unbal-
anced translocations showed the opposite result.
To date, there have been few studies that address the
indications for reciprocal translocation in amniocentesis, and
even fewer studies discussing the predictive rate of indications
for de novo reciprocal translocation.5,6 A recent large series
showed that advanced maternal age (AMA) was the most
frequent indication for amniocentesis, which revealed
a balanced reciprocal translocation,5 and that abnormal ultra-
sound findings were the most frequent indications in predict-
ing unbalanced reciprocal translocation.6 Although the
abovementioned data are available, we wanted to share our
data, based on 30 years’ experience in a single tertiary center,9
and study the indications and abnormality rates of amnio-
centesis. Our objective was to present data on all cases diag-
nosed with reciprocal translocation. Finally, we summarized
both data setsdthose previously published and oursdand
provided the largest body of domestic data as a reference,
which we believe will be of great value for couples who need
further genomic counseling.
2. Methods
Data were obtained from amniocentesis records of the
cytogenetic laboratory at Taipei Veterans General Hospital,
a tertiary medical center, for the years 1981e2010.9 DetailedTable 1
Frequency of reciprocal translocation according to different indications.
Anomaly
Amniocentesis in diff
Total AMA Abnormal
CVS
results
Abnormal
ultrasound
findings
Abnor
matern
serum
Reciprocal translocation
Current study 74 39 (52.7) 1 (1.4) 3 (4.1) 9 (12
Chen et al (2010, 2011) 127 47 (37.0) 0 (0) 15 (11.8) 10 (7.
Sum 201 86 (42.8) 1 (0.5) 18 (9.0) 19 (9.
Balanced reciprocal translocation
This study 56 30 (53.6) 1 (1.8) 1 (1.8) 8 (14
Chen et al (2010) 87 41 (47.1) 0 (0) 2 (2.3) 9 (10
Sum 143 71 (49.7) 1 (0.7) 3 (2.1) 17 (11
Unbalanced reciprocal translocation
This study 18 9 (50) 0 (0) 2 (11.1) 1 (6.
Chen et al (2011) 40 6 (15) 0 (0) 13 (32.5) 1 (2.
Sum 58 15 (25.9) 0 (0) 15 (25.9) 2 (3.
AMA ¼ advanced maternal age, that is, if the mother was 34 years of age
IUFD ¼ intrauterine fetal death.information on the indications for a prenatal diagnosis of
chromosomal abnormality with cytogenetic analysis has been
presented previously7 and includes the following: (1) AMA,
that is, if the mother was 34 years of age at the expected date
of confinement; (2) abnormal chorionic villus sampling (CVS)
results; (3) abnormal biochemical markers in maternal serum,
such as maternal blood Down syndrome screening (1/270);
(4) abnormal ultrasound findings; (5) an intrauterine fetal
death (IUFD); (6) a family history of chromosomal abnor-
malities; (7) a parent with abnormal karyotype; (8) a history of
abnormal offspring birth; (9) radiation or medication exposure
during pregnancy; and (10) other nonspecific indications such
as anxiety and consanguineous marriage.
Pieces of separate chromosomes breaking off of their
original chromosomes and switching places form reciprocal
translocation, which might cause loss or increase of genetic
material. The frequency of reciprocal translocation and de
novo type of reciprocal translocation in various indications
was estimated as the information for genetic counseling.
3. Results
A total of 16,749 amniocentesis cases were analyzed, and
74 of them involved reciprocal translocation. The highest
proportion of reciprocal translocations was found in cases with
the indications of AMA (52.7%, 39/74), abnormal biochem-
ical markers in maternal serum (12.2%, 9/74), and a parent
with an abnormal karyotype (17.6%, 13/74) (Table 1).
However, the proportions of reciprocal translocation were not
so obvious in cases with abnormal CVS results (1.4%, 1/74),
abnormal ultrasound findings (4.1%, 3/74), IUFDs (1.4%, 1/
74), a family history of chromosomal abnormality (1.4%, 1/
74), a history of abnormal offspring birth (1.4%, 1/74),
medication or radiation exposure (2.7%, 2/74), and other
nonspecific indications (2.7%, 2/74) (Table 1).
Fifty-six and 18 cases were balanced and unbalanced
reciprocal translocations, respectively (Table 1). Compatibleerent indications (number ¼ n/frequency ¼ %)
mal
al
marker
IUFD Family
history
Parental
abnormal
karyotype
Previous
abnormal
child
Radiation or
medication
exposure
Others
.2) 1 (1.4) 1 (1.4) 13 (17.6) 2 (2.7) 2 (2.7) 3 (4.1)
9) 0 (0) 0 (0) 45 (35.4) 5 (3.9) 0 (0) 5 (3.9)
5) 1 (0.5) 1 (0.5) 58 (28.9) 7 (5.0) 2 (1.0) 8 (4.0)
.3) 0 (0) 1 (1.8) 10 (17.9) 1 (1.8) 2 (3.6) 2 (3.6)
.3) 0 (0) 0 (0) 28 (32.2) 2 (2.3) 0 (0) 5 (5.8)
.9) 0 (0) 1 (0.7) 38 (26.6) 3 (2.1) 2 (1.4) 7 (4.9)
7) 1 (5.5) 0 (0) 3 (16.7) 1 (6.7) 0 (0) 1 (5.5)
5) 0 (0) 0 (0) 17 (42.5) 3 (7.5) 0 (0) 0 (0)
6) 1 (1.8) 0 (0) 20 (34.5) 4 (6.9) 0 (0) 1 (1.7)
at the expected date of confinement; CVS ¼ chorionic villus sampling;
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amniocentesis to detect reciprocal translocations, contributing
53.6% (30/56) in cases of balanced reciprocal translocations
and 60% (9/15) in cases of unbalanced reciprocal trans-
locations (Table 1). Two other indicationsdabnormal
biochemical markers in maternal serum and a parent with an
abnormal karyotypedwere also significant, since they
amounted to 14.3% (8/56) and 17.9% (10/56), respectively, of
all indications for amniocentesis in the detection of balanced
reciprocal translocations. In contrast, an abnormal maternal
serum marker was not obvious in cases of unbalanced recip-
rocal translocations.
In this study, AMA was the main indication for amnio-
centesis in the detection of de novo balanced reciprocal
translocations (47.1%, 8/17) and unbalanced reciprocal
translocations (66.7%, 4/6) (Table 2). The overall percentage
of reciprocal translocations in all amniocentesis cases was
0.44% (74/16,749) (Table 3). In an evaluation of the frequency
of reciprocal translocations in all indications, a parent with an
abnormal karyotype had the highest percentage (5.16%, 13/
252) (Table 3). None of the other indications, except abnormal
CVS results and IUFDs, had a detection rate above 2%. In the
evaluation of the percentage of de novo reciprocal trans-
locations, only abnormal CVS results reached 4%. Since the
case number for this indication was too small, compared with
other indications (Table 4), the clinical significance of the
results should be interpreted with caution.
4. Discussion
In this study, we found that AMAwas a major indication for
amniocentesis, sinceAMAcontributed to the highest proportion
of reciprocal translocations (more than one-half of cases,
compared with only one-third of cases in Chen et al’s study;
Table 1).5,6 However, cases involving a parent with an abnormal
karyotype contributed to a similar proportion (one-third of
cases) of indications for amniocentesis to detect reciprocal
translocations in Chen et al’s study,5,6 but contributed to only
one-sixth of the cases in this study. The reason for this
discrepancywas not clear, but it might be secondary to selection
bias and rapid molecular cytogenetic development (Chen was
a leader in cytogenetic diagnosis). Subsequently, these two
major indications (AMA plus a parent with an abnormal
karyotype) covered more than 70% (70.3% in our study and
72.4% in Chen et al’s studies3) of all cases of reciprocal trans-
locations that were diagnosed by amniocentesis. When we
summarized both data sets, we found that both AMA and
a parent with an abnormal karyotype contributed to 71.7% of
cases of reciprocal translocations diagnosed by amniocentesis,
suggesting that these two were the most important indications
for amniocentesis to detect reciprocal translocations.
The main indication for amniocentesis in Taiwan is
AMA,7e9 and this indication was found to be most important
in other countries as well,10,11 with the exception of one
study.12 AMA contributed to more than one-half of all indi-
cations for amniocentesis, ranging from 54.8% to 65.5% in
Taiwan7e9; therefore, it is understandable that the greatest
Table 3
Frequency of reciprocal translocation with different indications for
amniocentesis.
Indication Case
number (n)
Reciprocal
translocation (n)
Frequency of
abnormality (%)
AMA 10,970 39 0.36
Abnormal CVS results 25 1 4
Abnormal biochemical
markers in maternal serum
2090 9 0.43
Abnormal ultrasound findings 484 3 0.62
IUFD 50 1 2
Family history 183 1 0.55
Parent with abnormal
karyotype
252 13 5.16
Previous abnormal offspring 792 2 0.25
Radiation or
medication exposure
165 2 1.21
Others 1662 3 0.18
Total 16,749 74 0.44
AMA ¼ advanced maternal age, that is, if the mother was 34 years of age at
the expected date of confinement; CVS ¼ chorionic villus sampling;
IUFD ¼ intrauterine fetal death.
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under an AMA indication. However, the frequency of abnor-
mality seemed to be lower if we used AMA as an indication
for amniocentesis, since the frequency of any chromosomal
aberration was obviously lower than the frequency of other
indications for amniocentesis. In our previous study,6 the
frequency of the abnormality rate was only 2.47% when we
used AMA as an indication compared with 2.72% for all other
indications. This finding was also confirmed by other studies
(2.0% for AMA vs. 3.5% for all indications in one study7 and
2.3% for AMA vs. 2.9% for all indications in another study8).
In this study, we focused on the specific structural abnorma-
litydreciprocal translocationsdand also observed that only
0.36% of abnormalities were found with the indication of
AMA, but an overall 0.44% were found with all other
indications.
Although parents with abnormal karyotypes might not be
so obvious, compared with AMA as an indication for
amniocentesis in our previous study6 or this study, theTable 4
Frequency of de novo reciprocal translocation with different indications for
amniocentesis.
Indication Case
number (n)
Reciprocal
translocation (n)
Frequency
(%)
Advanced maternal age 10,970 12 0.11
Abnormal chorionic
villus sampling results
25 1 4
Abnormal biochemical
markers in maternal serum
2090 2 0.10
Abnormal ultrasound findings 484 3 0.62
Intrauterine fetal death 50 0 0
Family history 183 1 0.55
Parent with abnormal karyotype 252 0 0
Previous abnormal offspring birth 792 1 0.13
Radiation or medication exposure 165 1 0.61
Others 1662 2 0.12
Total 16,749 23 0.14indication of a parent with an abnormal karyotype contributed
to 17.6% of all cases diagnosed with reciprocal translocation.
A parent with an abnormal karyotype might be a much more
important indication for amniocentesis in detecting reciprocal
translocation, because other studies showed a higher propor-
tion (35.4%) for this than for all other indications for the
diagnosis of reciprocal translocations,4,5 and of great impor-
tance, this proportion was similar to that of AMA (37%),
which was conventionally considered as the most important
indication for amniocentesis.4e10 In this study, we emphasize
the importance of a parent with an abnormal karyotype as an
indication for amniocentesis, because we found that the
frequency of reciprocal translocations was much higher
(5.16%, or nearly 12-fold greater) than the overall frequency
of 0.44% for all indications for amniocentesis, when the
indication was a parent with an abnormal karyotype. In fact, in
our previous study,6 we reported a similar finding. Although
a parent with an abnormal karyotype contributed to only 1.5%
of all indications for amniocentesis, the rate of chromosomal
aberrations was higher, up to 11.51%, i.e., a nearly four-fold
increase of the overall rate (2.72%) of any chromosomal
aberration in all indications for amniocentesis. In addition,
a study in 1996 proposed that the overall risk at the second
trimester prenatal diagnosis was 14% (8/57) for unbalanced
reciprocal translocations in cases with one of the parents as
a reciprocal translocation carrier.12 Furthermore, the frequency
of de novo reciprocal translocations for the indication of
a parent with an abnormal karyotype and for all other indi-
cations (0.13% vs. 0.14%) (Table 4) was similar, suggesting
the importance of a hereditary pattern secondary to the parent.
Taken together, parents with an abnormal karyotype are
encouraged to undergo amniocentesis in prenatal consultation,
because not only is the overall detection rate of any chromo-
somal aberration high, but also the detection rate for the
specific type of chromosomal abnormality, for example,
reciprocal translocation, is much higher.
The role of abnormal biochemical markers in maternal
serum might be very similar to that of AMA, since the former
also contributed to one-tenth of all indications for amniocen-
tesis, and the frequency of detecting abnormality was nearly
equal to all indications. For example, in all chromosomal
aberrations, the rate of abnormality was 2.97%, compared with
2.72% in all indications.6 In this study, we further confirmed
this observation. Abnormal biochemical markers in maternal
serum contributed to 12% of all indications for amniocentesis
in diagnosing reciprocal translocations, but the frequency was
only 0.43%.
The other significant difference between the current study
and Chen et al’s study was the abnormal ultrasound findings.
In the current study, abnormal ultrasound findings contributed
to less than 5% of all indications with a diagnosis of reciprocal
translocation, but more than 10% in Chen et al’s study.4,5
Although the cause is not clear, the different experts in
ultrasound and cytogenesis at our institute, and of course
selection bias might explain this observation.
We also studied the proportion of different indications for
de novo reciprocal translocations. A study in 1991, collecting
157Y.-W. Chang et al. / Journal of the Chinese Medical Association 76 (2013) 153e15710-year data with 377,357 amniocentesis cases from cytoge-
netic laboratories in America and Canada, showed that
approximately 0.47/1000 had de novo reciprocal trans-
locations.13 One study using domestic data showed that
approximately 0.8/1000 had a de novo reciprocal trans-
location.14 Another study including 29 Italian laboratories
reported that approximately 0.68/1000 had a de novo recip-
rocal translocation.15 We found a higher prevalence of de novo
reciprocal translocation (1.4/1000) in this study (Table 4).
In conclusion, our study demonstrated that there were three
major indications for amniocentesis in diagnosing reciprocal
translocations. Although AMA was a leading indication for
reciprocal translocation, indication of parents with abnormal
karyotypes also shows high risk for this chromosome abnor-
mality, according to our data. We encourage careful consul-
tation for parents with abnormal karyotypes regarding further
genetic tests, including amniocentesis, since abnormal recip-
rocal translocation may cause loss or increase of genetic
material and it shows a significantly higher abnormality rate
than other indications for amniocentesis.
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